Discontinuation report TEVA-RABEPRAZOLE EC
Report ID | 120018 |
Drug Identification Number | 02296632 |
Brand name | TEVA-RABEPRAZOLE EC |
Common or Proper name | RABEPRAZOLE 10MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RABEPRAZOLE SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-03-25 |
Remaining supply date | 2020-03-25 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-10 | English | Compare |
v2 | 2020-07-10 | French | Compare |
Showing 1 to 2 of 2